Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Favipiravir
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Cobimetinib
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021
Ponatinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Bosutinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Sunitinib
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021
Ruxolitinib
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/02/2021
Acetylsalicylic acid
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
IVIg
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Interferon alfa
Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021
Interferon beta
Potential treatment - theoretical effect Used to treat other disease Antiviral May/12/2021
Astemizole
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/29/2021
Sarilumab 
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/29/2021
Chloroquine phosphate
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Menadione
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021
Camostat mesylate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021
Lopinavir
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021
Enoxaparin
Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/12/2021
Amsacrine
Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021
Palbociclib
Potential treatment - theoretical effect Used to treat other disease Other treatment Apr/12/2021